For healthcare professionals only


Court awards claimant $13.5m in rofecoxib lawsuit

BMJ 2006; 332 doi: (Published 20 April 2006) Cite this as: BMJ 2006;332:927
  1. Janice Hopkins Tanne
  1. New York

    A jury in New Jersey has awarded $4.5m (£2.6m; €3.7m) in compensatory damages to a 77 year old man who claimed that rofecoxib (Vioxx) had caused his heart attack. The jury decided that Merck, the maker of the cyclo-oxygenase-2 inhibitor, had deceived the US Food and Drug Administration about the safety of the drug and awarded the man an additional $9m in punitive damages.

    Merck said it had given the FDA all the necessary information about rofecoxib and would appeal the ruling.

    The jury decided that the heart attack …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription